Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Sales, net	$ 20,323	$ 16,732	$ 42,879	$ 33,991
Cost of sales	7,967	6,690	17,005	13,417
Gross profit	12,356	10,042	25,874	20,574
Operating expenses:
Sales and marketing	6,009	8,021	13,883	16,258
Research and development	1,365	1,245	2,558	2,323
General and administrative	7,298	7,163	13,717	16,112
Total operating expenses	14,672	16,429	30,158	34,693
Operating loss	(2,316)	(6,387)	(4,284)	(14,119)
Nonoperating income (expenses):
Interest income (expense), net	125	(10)	191	(18)
Net loss	$ (2,191)	$ (6,397)	$ (4,093)	$ (14,137)
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	$ (0.03)	$ (0.09)	$ (0.05)	$ (0.21)
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	$ (0.03)	$ (0.09)	$ (0.05)	$ (0.21)
Basic weighted average common shares outstanding (in shares)	74,967	68,336	74,882	68,325
Diluted weighted average common shares outstanding (in shares)	74,967	68,336	74,882	68,325